The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,778.00
Bid: 1,774.00
Ask: 1,774.50
Change: 0.00 (0.00%)
Spread: 0.50 (0.028%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,778.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Monday broker round-up UPDATE

Mon, 22nd Apr 2013 07:20

Admiral Group: Deutsche Bank takes target price from 1140p to 1300p retaining a hold recommendation.African Barrick Gold: Deutsche Bank ups target price from 173p to 180p staying with its hold recommendation.Albemarle & Bond: Canaccord Genuity reduces target price from 280p to 146p and downgrades from a speculative buy to hold.Anglo American: Deutsche Bank cuts target price from 2210p to 2170p, while its buy recommendation remains unaltered. HSBC Holdings moves target price from 2240p to 2250p and maintains an overweight rating.Antofagasta: HSBC Holdings moves target price from 1160p to 1080p and reiterates a neutral rating.AstraZeneca: Credit Suisse increases target price from 3050p to 3130p and maintains an underperform rating.BHP Billiton: HSBC Holdings reduces target price from 2250p to 2110p, while upgrading to overweight. Espirito Santo cuts target price from 1703p to 1605p, while upgrading to neutral.Brooks Macdonald: Canaccord Genuity revises target price from 1540p to 1620p keeping a buy recommendation.Brown (N) Group: HSBC Holdings takes target price from 430p to 485p and retains an overweight rating.Burford Capital: Espirito Santo revises target price from 149p to 140p and stays with its buy recommendation.Cable & Wireless Communications: Jefferies shifts target price from 40p to 42p and retains a hold recommendation.Chariot Oil & Gas: UBS cuts target price from 70p to 20p downgrading from buy to neutral.Electrocomponents: Goldman Sachs reduces target price from 311p to 277p and downgrades to neutral.Eurasian Natural Resources: Exane BNP raises target price from 270p to 320p staying with a neutral rating.GlaxoSmithKline: Credit Suisse increases target price from 1450p to 1670p and reiterates its neutral rating.Hansteen Holdings: Espirito Santo lowers target price from 76p to 85p maintaining a neutral rating.Ithaca Energy: Westhouse Securities ups target price from 165p to 200p and reiterates a buy recommendation. RBC Capital increases target price to 225p and keeps an outperform rating.Kazakhmys: Credit Suisse upgrades from underperform to neutral with its target price at 450p. Exane BNP increases target price from 350p to 390 upgrading to neutral.Legal & General Group: Deutsche Bank ups target price from 170p to 189p keeping a buy recommendation.Lloyds Banking Group: RBC Capital shifts target price from 69p to 65p and reiterates an outperform rating.NetDimensions: Sanlam Securities restarts with a target price of 80p and a buy recommendation.New World Resources: Exane BNP cuts target price from 180p to 165p and leaves its underperform rating unchanged.Premier Farnell: Goldman Sachs lowers target price from 240p to 226p and downgrades to neutral.Prudential: Deutsche Bank increases target price from 1060p to 1240p maintaining its buy recommendation.Reckitt Benckiser: Canaccord Genuity takes target price from 3425p to 4100p, but still recommends selling.Regus: JP Morgan shifts target price from 135p to 140p, while downgrading to underweight.Rentokil Initial: Deutsche Bank moves target price from 76p to 100p reiterating a hold recommendation.Resolution: Deutsche Bank lowers target price from 285p to 273p and keeps a hold recommendation.Rio Tinto: HSBC Holdings cuts target price from 4180p to 4160p, while its overweight rating remains unchanged. Espirito Santo raises target price from 2910p to 3160p and upgrades to neutral.Sagentia Group:Westhouse Securities downgrades from add to neutral with a target price of 107p.Segro: Espirito Santo shifts target price from 247p to 250p and leaves its neutral rating unchanged.Spectris: Goldman Sachs cuts target price from 3250p to 2850p maintaining a strong buy recommendation. Credit Suisse reduces target price from 2670p to 2350p and retains an outperform rating. UBS takes target price from 2700p to 2500p, while leaving its buy recommendation unchanged. Bank of America moves target price from 2080p to 1980p and keeps an underperform rating. JP Morgan reduces target price from 2575p to 2455p, while its overweight rating remains unchanged.Spirent Communications: Jefferies reduces target price from 196p to 140p keeping a buy recommendation. Investec places its target price (prev. 175p) under review reiterating its buy recommendation. Canaccord Genuity lowers target price from 135p to 120p and retains a hold recommendation.St James's Place: Deutsche Bank raises target price from 485p to 525p, while keeping a hold recommendation.Sweett Group: WH Ireland shifts target price from 27p to 33p and moves from a speculative buy to a buy rating.Talk Talk Telecom: Jefferies moves target price from 270p to 284p and maintains a buy recommendation. Credit Suisse raises target price from 200p to 275p and retains an outperform rating.Travis Perkins: Goldman Sachs downgrades from strong buy to buy with a target price of 1708p.Vedanta Resources: HSBC Holdings reduces target price from 1310p to 1280p and maintains its neutral rating.Vodafone Group: Jefferies shifts target price from 174p to 179p keeping a hold recommendation.Whitbread: Credit Suisse increases target price from 2760p to 2900p reiterating an outperform rating.William Hill: Nomura shifts target price from 333p to 339p and stays with its reduces rating. JP Morgan moves target price from 485p to 490p keeping an overweight rating.
More News
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more
30 Apr 2024 12:22

Sensodyne-maker Haleon to shut UK plant, 435 jobs to go

April 30 (Reuters) - Haleon, the world's largest standalone consumer healthcare firm, will shut its UK production site which makes Sensodyne toothpastes by 2026, leading to 435 job losses, a spokesperson said on Tuesday.

Read more
25 Apr 2024 15:53

GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology

April 25 (Reuters) - GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday, accusing them of infringing GSK patents related to messenger RNA (mRNA) technology in the companies' blockbuster COVID-19 vaccines.

Read more
24 Apr 2024 14:19

UK earnings, trading statements calendar - next 7 days

Thursday 25 April 
Aquila European Renewables PLCFull Year Results
Argo Blockchain PLCFull Year Results
AstraZeneca PLCQ1 Results
Barclays PLCQ1 Results
Checkit PLCFull Year Results
Coca-Cola Europacific Partners PLCTrading Statement
Destiny Pharma PLCFull Year Results
Dillistone Group PLCFull Year Results
Focusrite PLCHalf Year Results
Gem Diamonds LtdTrading Statement
Hikma Pharmaceuticals PLCTrading Statement
Hummingbird Resources PLCTrading Statement
Ibstock PLCTrading Statement
Inchcape PLCTrading Statement
J Sainsbury PLCFull Year Results
London Stock Exchange Group PLCQ1 Results
Persimmon PLCTrading Statement
Pinewood Technologies Group PLCFull Year Results
PPHE Hotel Group LtdTrading Statement
PureTech Health PLCFull Year Results
Relx PLCTrading Statement
Renewi PLCTrading Statement
Schroders PLCQ1 Results
Skillcast Group PLCFull Year Results
Travis Perkins PLCTrading Statement
Trifast PLCTrading Statement
Unilever PLCQ1 Results
WAG Payment Solutions PLCTrading Statement
Weir Group PLCTrading Statement
WH Smith PLCHalf Year Results
WPP PLCTrading Statement
Zinc Media Group PLCFull Year Results
Friday 26 April 
Facilities by ADF PLCFull Year Results
Kingspan Group PLCTrading Statement
Loungers PLCTrading Statement
NatWest Group PLC Q1 Results
Pearson PLCTrading Statement
Record PLCTrading Statement
Smurfit Kappa Group PLCTrading Statement
Taylor Maritime Investments LtdTrading Statement
Monday 29 April 
Beazley PLCTrading Statement
Biome Technologies PLCFull Year Results
Christie Group PLCFull Year Results
Gresham House Energy Storage Fund PLCFull Year Results
Gresham Technologies PLCFull Year Results
Jadestone Energy PLCFull Year Results
Oxford BioMedica PLCFull Year Results
SpaceandPeople PLCFull Year Results
Tuesday 30 April 
Avacta Group PLCFull Year Results
Card Factory PLCFull Year Results
Capital & Regional PLCFull Year Results
Close Brothers Group PLCTrading Statement
Coca-Cola HBC AGTrading Statement
Elementis PLCTrading Statement
essensys PLCHalf Year Results
Fadel Partners IncFull Year Results
Glencore PLCTrading Statement
Hargreaves Lansdown PLC Trading Statement
Howden Joinery PLCTrading Statement
HSBC Holdings PLCQ1 Results
Kelso Group PLCFull Year Results
Northcoders Group PLCFull Year Results
Phoenix Spree Deutschland LtdFull Year Results
RBG Holdings PLCFull Year Results
Rotork PLCTrading Statement
Safestore Holdings PLCHalf Year Results
Shield Therapeutics PLCFull Year Results
St James's Place PLCTrading Statement
Strip Tinning Holdings PLCFull Year Results
Whitbread PLCFull Year Results
Wednesday 1 May 
Computacenter PLCTrading Statement
GSK PLCQ1 Results
Haleon PLCTrading Statement
HSS Hire Group PLCFull Year Results
Intelligent Ultrasound Group PLCFull Year Results
Maintel Holdings PLCFull Year Results
Next PLCTrading Statement
Smith & Nephew PLCTrading Statement
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
24 Apr 2024 09:21

GSK's endometrial cancer drug receives FDA approval

(Sharecast News) - Drugmaker GSK said on Wednesday that the US Food and Drug Administration has accepted a supplemental Biologics License Application for Jemperli, its drug aimed at treating endometrial cancer.

Read more
24 Apr 2024 09:14

GSK's Jemperli with chemotherapy accepted for priority review by FDA

(Alliance News) - GSK PLC on Wednesday said that the US Food & Drug Administration has accepted a supplemental biologics licence application for Jemperli, when used in combination with chemotherapy.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.